Considering the effects of the treatment pipeline, NAC monotherapy application displayed a proficient effect in reverting PD motor deficits and DAT levels, thereby indicating that our therapeutical strategy could potentiate DAn functional integrity preservation. The gene discussed is SLC6A3; the disease is Parkinson disease.